Abingdon Health PLC (ABDX) Price & Analysis

Q: How many shares outstanding does Abingdon Health PLC have?

Abingdon Health PLC has 251,077,850 shares outstanding.

Q: What happened to Abingdon Health PLC’s price movement after its last earnings report?

Abingdon Health PLC reported an EPS of -0.004 p in its last earnings report, beating expectations of -0.006 p. Following the earnings report the stock price went down -7.143%.

Q: Which hedge fund is a major shareholder of Abingdon Health PLC?

Currently, no hedge funds are holding shares in GB:ABDX

Compare

22 Followers

ABDX Stock Chart & Stats

6.25 p

0.20 p(2.50%)

At close: Jan 09 4:00 PM EST

6.25 p

0.20 p(2.50%)

Day’s Range― - ―

52-Week Range5.10 p - 9.00 p

Previous CloseN/A

Volume7.61K

Average Volume (3M)78.74K

Market Cap

£20.71M

Enterprise Value15.08M

Total Cash (Recent Filing)£1.92M

Total Debt (Recent Filing)£1.03M

Price to Earnings (P/E)―

Beta-0.17

Next Earnings

Nov 18, 2026

EPS Estimate

<0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding251,077,850

10 Day Avg. Volume45,332

30 Day Avg. Volume78,736

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)4.84

Price to Sales (P/S)3.04

P/FCF Ratio-7.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)>-0.01

Revenue Forecast (FY)£12.20M

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained top-line growth across recent periods indicates expanding demand for Abingdon's rapid diagnostic tests and successful commercial traction. Durable revenue expansion supports scale economics, helps absorb fixed costs over time and provides a platform for reinvestment into product development and market expansion.

Manageable LeverageA relatively low debt-to-equity position gives the company financial flexibility to fund operations, R&D, and strategic partnerships without heavy interest burdens. This stronger balance sheet stance reduces refinancing risk and supports resilience across business cycles.

Specialized Diagnostics ModelA focused product set in point-of-care rapid diagnostics plus diversified revenue channels (direct sales, partnerships, licensing) creates structural advantages: deep domain expertise, recurring B2B channels, and optionality from collaborations that can drive stable mid-term revenue streams.

Bears Say

Negative ProfitabilityPersistent negative margins signal that core operations are not yet profitable, which impairs ability to self-fund growth and erodes return prospects. Without structural cost reductions or pricing power improvements, continued losses could necessitate dilutive financing or constrain strategic investments.

Weak Cash ConversionNegative operating cash flow despite revenue growth indicates difficulties converting earnings into usable cash. This weak cash conversion raises dependency on external funding for working capital and capex, increasing financing risk and limiting ability to scale sustainably over the medium term.

Negative Return On EquityA negative ROE shows the company is not generating returns on shareholders' capital, reflecting operational inefficiency or margin pressure. Over time, this undermines investor capital formation and suggests management must improve margins or asset utilization to create durable shareholder value.

Abingdon Health PLC News

Abingdon Health lifts revenues 45% and targets profitable second half

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health reported unaudited first-half FY26...

8h ago

Abingdon Health Wins $2.5m Clinical Self-Test Contract, Bolstering Diagnostics Role

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health plc, a U.K.-based med-tech...

5d ago

Abingdon Health Targets US Investors With OTCQB Listing After Wisconsin Expansion

Abingdon Health PLC ( ($GB:ABDX) ) has issued an announcement. Abingdon Health is deepening its US presence by...

7d ago

Abingdon Health Sets Date for Interim Results and Investor Presentation

Abingdon Health PLC ( ($GB:ABDX) ) has shared an update. Abingdon Health plc, an AIM-quoted international developer, manufacturer...

12d ago

Abingdon Health lifts H1 revenues 45% and backs full-year guidance amid US expansion

Abingdon Health PLC ( ($GB:ABDX) ) has shared an update. Abingdon Health reported a 45% rise in first-half...

2M ago

Abingdon Health Names Cavendish as Sole Broker and Nominated Adviser

Abingdon Health PLC ( ($GB:ABDX) ) has provided an update. Abingdon Health plc, a specialist in rapid diagnostic...

2M ago

Abingdon Health Updates Share Capital Following Option Exercise

Abingdon Health PLC ( ($GB:ABDX) ) has issued an announcement. Abingdon Health plc, an international developer and manufacturer...

3M ago

Abingdon Health Secures European Patent for Innovative Smartphone-Based Diagnostics

Abingdon Health PLC ( ($GB:ABDX) ) has shared an announcement. Abingdon Health PLC has secured a European patent...

3M ago

Abingdon Health PLC Secures Strong Shareholder Support at AGM

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health PLC announced that all...

3M ago

Abingdon Health Updates LTIP with New Share Awards

Abingdon Health PLC ( ($GB:ABDX) ) just unveiled an announcement. Abingdon Health PLC announced updates to its Long...

3M ago

ABDX FAQ

What was Abingdon Health PLC’s price range in the past 12 months?

Abingdon Health PLC lowest share price was 5.10 p and its highest was 9.00 p in the past 12 months.

What is Abingdon Health PLC’s market cap?

Abingdon Health PLC’s market cap is £20.71M.

When is Abingdon Health PLC’s upcoming earnings report date?

Abingdon Health PLC’s upcoming earnings report date is Nov 18, 2026 which is in 246 days.

How were Abingdon Health PLC’s earnings last quarter?

Abingdon Health PLC released its earnings results on Mar 17, 2026. The company reported -0.004 p earnings per share for the quarter, beating the consensus estimate of -0.006 p by 0.002 p.

Is Abingdon Health PLC overvalued?

According to Wall Street analysts Abingdon Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Abingdon Health PLC pay dividends?

Abingdon Health PLC does not currently pay dividends.

What is Abingdon Health PLC’s EPS estimate?

Abingdon Health PLC’s EPS estimate is <0.01.

How many shares outstanding does Abingdon Health PLC have?

Abingdon Health PLC has 251,077,850 shares outstanding.

What happened to Abingdon Health PLC’s price movement after its last earnings report?

Abingdon Health PLC reported an EPS of -0.004 p in its last earnings report, beating expectations of -0.006 p. Following the earnings report the stock price went down -7.143%.

Which hedge fund is a major shareholder of Abingdon Health PLC?

Currently, no hedge funds are holding shares in GB:ABDX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Abingdon Health PLC

Abingdon Health PLC (ABDX) is a UK-based company specializing in the development and manufacture of rapid diagnostic tests. The company focuses on providing innovative solutions in the healthcare sector, particularly in the fields of infectious diseases, including COVID-19 testing, and other point-of-care testing applications. Abingdon Health aims to enhance patient outcomes through its high-quality, reliable diagnostics that are designed for use in various settings, ranging from hospitals to home testing.